Recent Finacing
Recent Raise
Asieris Pharmaceuticals is a Shanghai-based oncology biotech developing MetAP2 inhibitor APL-1202 for relapsed non‑muscle invasive bladder cancer and advancing multiple oncology drug candidates toward clinical Phase III in China.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
